Communiqués NuCana plc

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
2,55 ^USD	-6,93%		-14,00%	-65,52%

28/06	Les actions européennes négociées aux États-Unis et les American Depositary Receipts sont en légère hausse vendredi matin	MT
20/06	Les actions européennes négociées aux États-Unis et les American Depositary Receipts évoluent à la hausse dans les échanges de jeudi	MT

NuCana : Presentation - June 2024	10/06	PU
NuCana to Present at the Jefferies Global Healthcare Conference	30/05	AQ
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit	21/05	AQ
NUCANA : UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Form 6-K	16/05	PU
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update	16/05	AQ
NuCana : Notice of Annual General Meeting - Form 6-K	13/05	PU
NuCana : Annual Report - 2023	13/05	PU
NuCana : Notice of AGM - 2024	13/05	PU
NuCana : Presentation - May 2024	02/05	PU
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement	01/05	AQ
NuCana Announces Completion of ADS Ratio Change	16/04	GL
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study	09/04	GL
NuCana : Presentation - April 2024	02/04	PU
NuCana Announces Plan to Implement ADS Ratio Change	27/03	GL
NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update	20/03	GL
NuCana : Presentation - March 2024	12/03	PU
NuCana to Present at TD Cowen's 44th Annual Health Care Conference	28/02	AQ
NuCana to Present at TD Cowen’s 44th Annual Health Care Conference	27/02	GL
NuCana to Present at TD Cowen’s 44th Annual Health Care Conference	27/02	AQ
NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	GL

Aucun résultat pour cette recherche